Clincosm LogoSign in Get a demo

refractory central nervous system lymphoma

Showing 1 - 3 of 3
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CNS B-Cell Non-Hodgkin Lymphoma, Recurrent CNS Lymphoma, Refractory CNS Lymphoma Trial in Houston (Ibrutinib, Nivolumab)

Recruiting
  • Central Nervous System B-Cell Non-Hodgkin Lymphoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Refractory CNS Lymphoma, Relapsed Primary CNS Lymphoma, Primary CNS Lymphoma Trial in Hangzhou (Nivolumab)

Active, not recruiting
  • Refractory Central Nervous System Lymphoma
  • +2 more
  • Hangzhou, Zhejiang, China
    Jianmin Zhang
Jul 3, 2022

Recurrent CNS Lymphoma, Recurrent DLBCL, Refractory CNS Lymphoma Trial in Nashville (Nivolumab, Rituximab, Lenalidomide)

Terminated
  • Recurrent Central Nervous System Lymphoma
  • +3 more
  • Nivolumab
  • +2 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Apr 23, 2019